Chemoinformaics analysis of 5-ALPHA-PREGNAN-3-BETA,20-BETA-DIOL
| Molecular Weight | 512.531 | nRot | 3 |
| Heavy Atom Molecular Weight | 478.259 | nRig | 22 |
| Exact Molecular Weight | 512.236 | nRing | 4 |
| Solubility: LogS | -6.388 | nHRing | 0 |
| Solubility: LogP | 5.55 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 69 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 70.971 |
| nHD | 0 | BPOL | 45.995 |
| QED | 0.315 |
| Synth | 4.588 |
| Natural Product Likeliness | 1.388 |
| NR-PPAR-gamma | 0.736 |
| Lipinski | Rejected |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.999 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.661 |
| MDCK | 0.0000104 |
| BBB | 0.456 |
| PPB | 0.986031 |
| VDSS | 1.147 |
| FU | 0.00929332 |
| CYP1A2-inh | 0.072 |
| CYP1A2-sub | 0.409 |
| CYP2c19-inh | 0.085 |
| CYP2c19-sub | 0.806 |
| CYP2c9-inh | 0.187 |
| CYP2c9-sub | 0.696 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.823 |
| CYP3a4-inh | 0.387 |
| CYP3a4-sub | 0.232 |
| CL | 6.893 |
| T12 | 0.005 |
| hERG | 0.082 |
| Ames | 0.008 |
| ROA | 0.148 |
| SkinSen | 0.077 |
| Carcinogencity | 0.506 |
| EI | 0.011 |
| Respiratory | 0.965 |
| NR-Aromatase | 0.127 |
| Antiviral | Yes |
| Prediction | 0.786871 |